热门资讯> 正文
2025-08-08 04:56
Pliant Therapeutics (NASDAQ: PLRX) reported quarterly losses of $(0.71) per share which met the analyst consensus estimate. This is a 22.83 percent increase over losses of $(0.92) per share from the same period last year.